In many cases of GBM, an increased activity of mTOR signaling results in elevated cell proliferation and cell survival, with a simultaneous reduction in apoptosis, thereby promoting tumorigenesis and treatment resistance [57, 58]. The gene discussed is MTOR; the disease is glioblastoma.